亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

CAS號:465-21-4 蟾毒靈

 
 
單價 面議對比
詢價 暫無
發貨 陜西寶雞市付款后3天內
品牌 herbest
型號 465-21-4
規格 HPLC>98%
過期 長期有效
更新 2013-08-06 09:36
 

寶雞市辰光生物科技有限公司.

企業會員第13年
資料未認證
保證金未繳納
詳細說明
 

中文名稱:蟾毒靈
英文名稱:Bufalin
CAS
號:465-21-4
純度:HPLC>98%

 

詳細介紹:

蟾毒靈
英文名稱:Bufalin
來源:蟾酥提取物;蟾蜍科動物如中華大蟾蜍Bufo bufo gargarizans Cantor的干燥分泌物

產品基本信息:
純度:蟾毒靈 HPLC>98%
CAS
: 465-21-4
分子量:386.52g/mol
分子式:C24H34O4

HPLC 檢測條件:
C18
4.6 ×250mm)
流動相:**:0.5%禁發此化學品溶液(50:50)
檢測波長: 296nm


包裝及庫存:

品 名

規 格

數 量

庫存

蟾毒靈Bufalin

HPLC>98%

20mg

YES

蟾毒靈Bufalin

HPLC>98%

1000mg

YES

同系列其它產品:

品 名

CAS 號

規 格

華蟾毒它靈Cinobufotalin

1108-68-5

HPLC>98%

沙蟾毒精Arenobufagin

464-74-4

HPLC>98%

日蟾蜍他靈,和蟾蜍他Gamabufotalin

465-11-2

HPLC>98%

蟾蜍他靈,蟾蜍它靈Bufotalin

471-95-4

HPLC>98%

遠華蟾蜍精Telocinobufagin

472-26-4

HPLC>98%

華蟾酥毒基;華蟾毒精Cinobufagin

470-37-1

HPLC>98%

酯蟾毒配基;蟾力蘇Resibufogenin

465-39-4

HPLC>98%

去乙酰華蟾毒它靈Desacetylcinobufotalin

N/A

HPLC>95%

去乙酰華蟾毒精Desacetylcinobufagin

N/A

HPLC>95%

舉報收藏 0評論 0
更多>本企業其它產品
偽異沙蟾毒精 CAS號:17008-65-0 穿心蓮內酯 CAS號:5508-58-7 寶藿苷Ⅰ CAS號:113558-15-9 金絲桃苷 CAS號:482-36-0 葫蘆素E CAS號:18444-66-1 CAS號:568-72-9 丹參酮IIA CAS號:118525-40-9 脫水淫羊藿素
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |